Commonwealth Equity Services’s IGC Pharma IGC Stock Holding History

Commonwealth Equity Services’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.9K	Buy	33,848 +500	+1%	+$139	﹤0.01%	4287
2025 Q4	$9.38K	Sell	33,348 -1,600	-5%	-$570	﹤0.01%	4265
2025 Q3	$15K	Hold	34,948	–	–	﹤0.01%	4216
2025 Q2	$11K	Buy	34,948 +348	+1%	+$105	﹤0.01%	4231
2025 Q1	$10K	Hold	34,600	–	–	﹤0.01%	4148
2024 Q4	$12K	Sell	34,600 -10,000	-22%	-$3.74K	﹤0.01%	4064
2024 Q3	$19K	Buy	44,600 +10,000	+29%	+$4.01K	﹤0.01%	3999
2024 Q2	$15K	Buy	+34,600	New	+$17.2K	﹤0.01%	3981
2023 Q4	–	Sell	-165,490	Closed	-$59K	–	3962
2023 Q3	$59K	Buy	165,490 +112,334	+211%	+$40.2K	﹤0.01%	3642
2023 Q2	$17K	Hold	53,156	–	–	﹤0.01%	3758
2023 Q1	$18	Sell	53,156 -650	-1%	-$244	﹤0.01%	3681
2022 Q4	$17K	Sell	53,806 -150	-0.3%	-$61	﹤0.01%	3611
2022 Q3	$23K	Buy	53,956 +3,706	+7%	+$1.98K	﹤0.01%	3563
2022 Q2	$26K	Buy	+50,250	New	+$31.7K	﹤0.01%	3549

Other funds holding IGC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lawood & Co Williamsport, Pennsylvania $148M AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commonwealth Equity Services's IGC Position: Q1 2026 in Review

Commonwealth Equity Services increased its IGC Pharma (IGC) stake by 1.5% in Q1 2026, buying an estimated $139 and bringing the position to 33,848 shares worth $8.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4287.

Commonwealth Equity Services first reported a position in IGC in Q2 2022 and has held it in 14 quarters since. The position peaked at $59K in Q3 2023. 35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

Commonwealth Equity Services held 33,848 shares of IGC Pharma worth $8.9K as of Q1 2026.
Commonwealth Equity Services bought 500 IGC Pharma shares in Q1 2026, an estimated $139.
IGC Pharma made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #4287 holding.
Commonwealth Equity Services first reported a position in IGC Pharma in Q2 2022 and has held it in 14 quarters since.
Commonwealth Equity Services's IGC Pharma position peaked at $59K in Q3 2023.
35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.